- Silo Wellness is a psychedelic wellness company with a parallel track focusing on developing wellness facilities and a psilocybin- or derivative-based treatment.
- Silo Wellness is the only publicly traded company with an operational foothold in Oregon that replicates its proof of concept for psilocybin in Jamaica.
- The company’s Jamaican psychedelic wellness retreats provide a current revenue stream.
- An experienced team of managers and scientists lead the company towards its goals of widespread treatment with psilocybin-based treatments.
- Silo Wellness recently acquired 100 percent of Dyscovry Science Ltd., a Toronto-based biotechnology company focused on biosynthetic manufacturing of psilocybin and its derivatives targeting irritable bowel syndrome.
Psychedelics have long been believed to have medicinal value, and now a growing body of research supports that theory. Johns Hopkins has published over 60 peer-reviewed studies on the topic, reflecting research into how psychedelics can impact behavior, cognition and brain function. The University of Texas even opened a new center to study how psychedelics can be used to treat depression, PTSD and anxiety. Research paved the way for the cannabis industry, and now psychedelics are not far behind.
In the US, Oregon became the first state to legalize psychedelics in 2020 with Measure 109 for medicinal administration, and now other states are following suit. US Rep. Alexandria Ocasio-Cortez also filed a measure to remove a 90s-era provision on psychedelics. While it was rejected, the vote has never been closer — a sign that we may see the federal government reducing its restrictions on psychedelics soon. Companies pursuing the field of psychedelic medical treatment now are poised for success as legal barriers are removed, either at the state or federal level.Silo Wellness (CSE:SILO, OTCQB:SILFF) is a psychedelic wellness company pursuing two parallel tracks to capitalize on the growing market fully. First, biotech research represents its long-term track, with the second track focusing on providing services in jurisdictions where legal barriers have been removed. The company, which was founded in Oregon by an Oregon lawyer, has previously launched Oregon’s first legal psychedelic retreats via ketamine (also a U.S. legal first). Silo Wellness is pursuing treatment programs in Oregon under Ballot Measure 109 and has a proof-of-concept center in Jamaica. Combined, the company has a unique combination of business lines for both near-term and long-term revenue.